Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Blute, ML' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Elliott, DS; Segura, JW; Lightner, D; Patterson, DE; Blute, ML
      Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management ofupper tract transitional cell carcinoma in individuals with a normal contralateral kidney

      UROLOGY
    2. Roberts, WW; Bergstralh, EJ; Blute, ML; Slezak, JM; Carducci, M; Han, M; Epstein, JI; Eisenberger, MA; Walsh, PC; Partin, AW
      Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy

      UROLOGY
    3. Alberts, SR; Blute, ML
      Chemoprevention for prostatic carcinoma: The role of flutamide in patientswith prostatic intraepithelial neoplasia

      UROLOGY
    4. Roberts, SG; Blute, ML; Bergstralh, EJ; Slezak, JM; Zincke, H
      PSA doubling time as a predictor of clinical progression after biochemicalfailure following radical prostatectomy for prostate cancer

      MAYO CLINIC PROCEEDINGS
    5. Elliott, DS; Lightner, DJ; Blute, ML
      Medical management of overactive bladder

      MAYO CLINIC PROCEEDINGS
    6. Zincke, H; Lau, W; Bergstralh, E; Blute, ML
      Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer

      JOURNAL OF UROLOGY
    7. Lau, WK; Blute, ML; Bostwick, DG; Weaver, AL; Sebo, TJ; Zincke, H
      Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4

      JOURNAL OF UROLOGY
    8. Cheville, JC; Blute, ML; Zincke, H; Lohse, CM; Weaver, AL
      Stage pT1 conventional (clear cell) renal cell carcinoma: Pathological features associated with cancer specific survival

      JOURNAL OF UROLOGY
    9. Amling, CL; Bergstralh, EJ; Blute, ML; Slezak, JM; Zincke, H
      Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?

      JOURNAL OF UROLOGY
    10. Blute, ML; Bergstralh, EJ; Iocca, A; Scherer, B; Zincke, H
      Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy

      JOURNAL OF UROLOGY
    11. Wang, L; McDonnell, SK; Elkins, DA; Slager, SL; Christensen, E; Marks, AF; Cunningham, JM; Peterson, BJ; Jacobsen, SJ; Cerhan, JR; Blute, ML; Schaid, DJ; Thibodeau, SN
      Role of HPC2/ELAC2 in hereditary prostate cancer

      CANCER RESEARCH
    12. Gettman, MT; Blute, ML; Spotts, B; Bryant, SC; Zincke, H
      Pathologic staging of renal cell carcinoma - Significance of tumor classification with the 1997 TNM staging system

      CANCER
    13. Barry, MJ; Albertsen, PC; Bagshaw, MA; Blute, ML; Cox, R; Middleton, RG; Gleason, DF; Zincke, H; Bergstralh, EJ; Jacobsen, SJ
      Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management - A retrospective analysis

      CANCER
    14. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    15. Cheng, L; Zincke, H; Blute, ML; Bergstralh, EJ; Scherer, B; Bostwick, DG
      Risk of prostate carcinoma death in patients with lymph node metastasis

      CANCER
    16. Cheng, L; Zincke, H; Blute, ML; Bergstralh, EJ; Scherer, D; Bostwick, DG
      Risk of prostate carcinoma death in patients with lymph node metastasis

      CANCER CYTOPATHOLOGY
    17. Cheng, L; Lloyd, RV; Weaver, AL; Pisansky, TM; Cheville, JC; Ramnani, DM; Leibovich, BC; Blute, ML; Zincke, H; Bostwick, DG
      The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy

      CLINICAL CANCER RESEARCH
    18. Leibovich, BC; Blute, ML; Bostwick, DG; Wilson, TM; Pisansky, TM; Davis, BJ; Ramnani, DM; Cheng, L; Sebo, TJ; Zincke, H
      Proximity of prostate cancer to the urethra: Implications for minimally invasive ablative therapies

      UROLOGY
    19. Lau, WKO; Blute, ML; Weaver, AL; Torres, VE; Zincke, H
      Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney

      MAYO CLINIC PROCEEDINGS
    20. Blute, ML; Amling, CL; Bryant, SC; Zincke, H
      Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease

      MAYO CLINIC PROCEEDINGS
    21. Blute, ML; Bergstralh, EJ; Partin, AW; Walsh, PC; Kattan, MW; Scardino, PT; Montie, JE; Pearson, JD; Slezak, JM; Zincke, H
      Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer

      JOURNAL OF UROLOGY
    22. O'Leary, MP; Gee, WF; Holtgrewe, HL; Blute, ML; Cooper, TP; Miles, BJ; Nellans, RE; Thomas, R; Painter, MR; Meyer, JJ; Naslund, MJ; Gormley, EA; Blizzard, R; Fenninger, RB
      1999 American Urological Association Gallup Survey: Changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care

      JOURNAL OF UROLOGY
    23. Karnes, RJ; Gettman, MT; Anderson, PM; Lager, DJ; Blute, ML
      Primitive neuroectodermal tumor (extraskeletal Ewing's sarcoma) of the kidney with vena caval tumor thrombus

      JOURNAL OF UROLOGY
    24. Itano, NB; Blute, ML; Spotts, B; Zincke, H
      Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy

      JOURNAL OF UROLOGY
    25. Amling, CL; Blute, ML; Bergstralh, EJ; Seay, TM; Slezak, J; Zincke, H
      Long-term hazard of progression after radical prostatectomy for clinicallylocalized prostate cancer: Continued rise of biochemical failure after 5 years

      JOURNAL OF UROLOGY
    26. Knight, MK; Blute, ML
      Incidental discovery of pelvic leiomyosarcoma at radial prostatectomy

      JOURNAL OF UROLOGY
    27. Leibovich, BC; Engen, DE; Patterson, DE; Pisansky, TM; Alexander, EE; Blute, ML; Bergstralh, EJ; Zincke, H
      Benefit of adjuvant radiation therapy for localized prostate cancer with apositive surgical margin

      JOURNAL OF UROLOGY
    28. Blute, ML
      Management of superficial transitional cell carcinoma in the intramural ureter: What to do? Editorial comment

      JOURNAL OF UROLOGY
    29. Pisansky, TM; Kozelsky, TF; Myers, RP; Hillman, DW; Blute, ML; Buskirk, SJ; Cheville, JC; Ferrigni, RG; Schild, SE
      Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

      JOURNAL OF UROLOGY
    30. Berry, R; Schaid, DJ; Smith, JR; French, AJ; Schroeder, JJ; McDonnell, SK; Peterson, BJ; Wang, ZY; Carpten, JD; Roberts, SG; Tester, DJ; Blute, ML; Trent, JM; Thibodeau, SN
      Linkage analyses at the chromosome 1 Loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    31. Cheng, L; Pisansky, TM; Sebo, TJ; Leibovich, BC; Ramnani, DM; Weaver, AL; Scherer, BG; Blute, ML; Zincke, H; Bostwick, DG
      Cell proliferation in prostate cancer patients with lymph node metastasis:A marker for progression

      CLINICAL CANCER RESEARCH
    32. Seelig, MH; Oldenburg, WA; Klingler, PJ; BLute, ML; Pairolero, PC
      Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Guerin therapy

      JOURNAL OF VASCULAR SURGERY
    33. Seay, TM; Blute, ML; Zincke, H
      Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate (vol 50, pg 833, 1997)

      UROLOGY
    34. Ghavamian, R; Blute, ML; Bergstralh, EJ; Slezak, J; Zincke, H
      Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

      UROLOGY
    35. Noel, AA; Gloviczki, P; Cherry, KJ; Bower, TC; Hallett, JW; Panneton, JM; Whitley, D; Blute, ML; Stanson, AW
      Optimal management of abdominal aortic aneurysms and urologic malignancies: Benefits of simultaneous surgical treatment

      VASCULAR SURGERY
    36. Blute, ML
      Nephron sparing surgery for localized renal cell carcinoma: Impact of tumorsize on patient survival, tumor recurrence and TNM staging - Comment

      JOURNAL OF UROLOGY
    37. O'Leary, MP; Gee, WF; Holtgrewe, HL; Blute, ML; Cooper, TP; Meyer, JJ; Miles, BJ; Naslund, MJ; Nellans, RE; Thomas, R; Painter, MR; Blizzard, R; Fenninger, RB
      1998 American Urological Association Gallup Survey: Changes in physician practice patterns, treatment of ureteral stones and impact of managed care

      JOURNAL OF UROLOGY
    38. Dechet, CB; Sebo, T; Farrow, G; Blute, ML; Engen, DE; Zincke, H
      Prospective analysis of intraoperative frozen needle biopsy of solid renalmasses in adults

      JOURNAL OF UROLOGY
    39. Blute, ML; Zincke, H
      Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology

      JOURNAL OF UROLOGY
    40. Ghavamian, R; Bergstralh, EJ; Blute, ML; Slezak, J; Zincke, H
      Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison

      JOURNAL OF UROLOGY
    41. Ghavamian, R; Bergstralh, EJ; Blute, ML; Slezak, J; Zincke, H
      Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison - Reply

      JOURNAL OF UROLOGY
    42. Amling, CL; Lerner, SE; Martin, SK; Slezak, JM; Blute, ML; Zincke, H
      Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer

      JOURNAL OF UROLOGY
    43. Ramakumar, S; Bhuiyan, J; Besse, JA; Roberts, SC; Wollan, PC; Blute, ML; O'Kane, DJ
      Comparison of screening methods in detection of bladder cancer

      JOURNAL OF UROLOGY
    44. Corica, FA; Iczkowski, KA; Cheng, L; Zincke, H; Blute, ML; Wendel, A; Sebo, TJ; Neumann, R; Bostwick, DG
      Cystic renal cell carcinoma is cured by resection: A study of 24 cases with long-term followup

      JOURNAL OF UROLOGY
    45. Blute, ML
      The value of upper tract cytology after transurethral resection of bladdertumor in patients with bladder transitional cell cancer - Editorial comment

      JOURNAL OF UROLOGY
    46. Cheng, L; Bergstralh, EJ; Scherer, BG; Neumann, RM; Blute, ML; Zincke, H; Bostwick, DG
      Predictors of cancer progression in T1a prostate adenocarcinoma

      CANCER
    47. DELAROSETTE JJMCH; BLUTE ML; DESGRANDCHAMP F
      TRANSURETHRAL THERMOTHERAPY USING THE PROSTATRON DEVICE

      World journal of urology
    48. Cheng, L; Bergstralh, EJ; Cheville, JC; Slezak, J; Corica, FA; Zincke, H; Blute, ML; Bostwick, DG
      Cancer volume of lymph node metastasis predicts progression in prostate cancer

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    49. DJAVAN B; LARSON TR; BLUTE ML; MARBERGER M
      TRANSURETHRAL MICROWAVE THERMOTHERAPY - WHAT ROLE SHOULD IT PLAY VERSUS MEDICAL-MANAGEMENT IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

      Urology
    50. LARSON TR; BLUTE ML; TRI JL; WHITLOCK SV
      CONTRASTING HEATING PATTERNS AND EFFICIENCY OF THE PROSTATRON AND TARGIS MICROWAVE ANTENNAE FOR THERMAL-TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

      Urology
    51. LARSON TR; BLUTE ML; BRUSKEWITZ RC; MAYER RD; UGARTE RR; UTZ WJ
      A HIGH-EFFICIENCY MICROWAVE THERMOABLATION SYSTEM FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - RESULTS OF A RANDOMIZED, SHAM-CONTROLLED, PROSPECTIVE, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL

      Urology
    52. BLUTE ML; GBUREK BM
      CONTINENT ORTHOTOPIC URINARY-DIVERSION IN FEMALE-PATIENTS - EARLY MAYO-CLINIC EXPERIENCE

      Mayo Clinic proceedings
    53. BLUTE ML; LARSON TR; HANSON KA; KING BF
      CURRENT STATUS OF TRANSURETHRAL THERMOTHERAPY AT THE MAYO-CLINIC

      Mayo Clinic proceedings
    54. AMLING CL; BLUTE ML; LERNER SE; BERGSTRALH EJ; BOSTWICK DG; ZINCKE H
      INFLUENCE OF PROSTATE-SPECIFIC ANTIGEN TESTING ON THE SPECTRUM OF PATIENTS WITH PROSTATE-CANCER UNDERGOING RADICAL PROSTATECTOMY AT A LARGEREFERRAL PRACTICE

      Mayo Clinic proceedings
    55. GEE WF; HOLTGREWE HL; BLUTE ML; MILES BJ; NASLUND HJ; NELLANS RE; OLEARY MP; THOMAS R; PAINTER MR; MEYER JJ; ROHNER TJ; COOPER TP; BLIZZARD R; FENNINGER RB; EMMONS L
      1997 AMERICAN-UROLOGICAL-ASSOCIATION GALLUP SURVEY - CHANGES IN DIAGNOSIS AND MANAGEMENT OF PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA, AND OTHER PRACTICE TRENDS FROM 1994 TO 1997

      The Journal of urology
    56. GBUREK BM; LIEBER MM; BLUTE ML
      COMPARISON OF STUDER ILEAL NEOBLADDER AND ILEAL CONDUIT URINARY-DIVERSION WITH RESPECT TO PERIOPERATIVE OUTCOME AND LATE COMPLICATIONS

      The Journal of urology
    57. BLUTE ML
      TEMPERATURE-CONTROLLED HIGH-ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA USING A HEAT-SHOCK STRATEGY - COMMENT

      The Journal of urology
    58. BLUTE ML
      DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR - EDITORIAL COMMENT

      The Journal of urology
    59. AMLING CL; BERGSTRALH EJ; BLUTE ML; ZINCKE H
      FACTORS PREDICTING OUTCOME FOLLOWING RADICAL PROSTATECTOMY FOR DNA ANEUPLOID PROSTATE-CANCER

      The Journal of urology
    60. AMLING CL; BERGSTRALH EJ; BLUTE ML; ZINCKE H
      PROSTATE-CANCER PROGRESSION RATES FOLLOWING RADICAL PROSTATECTOMY IN PATIENTS WITH SEMINAL-VESICLE INVOLVEMENT

      The Journal of urology
    61. BLUTE ML; AMLING CL; BRYANT SC; ZINCKE H
      MANAGEMENT AND OUTCOME OF BILATERAL SYNCHRONOUS SOLID RENAL NEOPLASMS

      The Journal of urology
    62. ZINCKE H; DECHET CB; BLUTE ML; ENGEN DE; SEBO T
      NEEDLE-BIOPSY OF SOLID RENAL MASSES

      The Journal of urology
    63. DECHET CB; BLUTE ML; ZINCKE H
      NEPHRON-PRESERVING SURGERY FOR UNILATERAL RENAL-CELL CARCINOMA - WHICH PATHOLOGICAL VARIABLES CONTRIBUTE TO CONTRALATERAL RENAL TUMOR RECURRENCE

      The Journal of urology
    64. PETERSON D; GHAVAMIAN R; WOLLAN PC; ZINCKE H; BLUTE ML
      EXTENDED OUTCOME OF RENAL PRESERVING SURGERY IN SOLITARY KIDNEYS

      The Journal of urology
    65. SLEZAK J; GHAVAMIAN R; BERGSTRALH EJ; BLUTE ML; ZINCKE H
      COMPARISON OF OUTCOMES IN C-T1C VERSUS C-T2 PROSTATE-CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY

      The Journal of urology
    66. KAUSIK SJ; BLUTE ML; BERGSTRALH EJ; SLEZAK J; ZINCKE H
      EVALUATION OF POSITIVE MARGINS IN LIMITED EXTRACAPSULAR PROSTATE-CANCER AND ITS IMPACT ON OUTCOME AFTER RADICAL PROSTATECTOMY

      The Journal of urology
    67. DANGELO MF; HANSON KA; KING BF; PATTERSON DE; LARSON TR; COLLINS JM; BLUTE ML
      PROSPECTIVE, COMPARATIVE-ANALYSIS OF MRI GADOLINIUM-ENHANCED CENTRAL ZONE PERFUSION DEFECTS USING THE PROSTATRON-2.0 AND THE TARGIS THERMOTHERAPY DEVICES

      The Journal of urology
    68. GHAVAMIAN R; BERGSTRALH EJ; SLEZAK J; BLUTE ML; ZINCKE H
      RADICAL RETROPUBIC PROSTATECTOMY PLUS ORCHIECTOMY VERSUS ORCHIECTOMY ALONE FOR PTXN-CANCER - A MATCHED COMPARISON( PROSTATE)

      The Journal of urology
    69. SLEZAK JM; AMLING CL; LERNER SE; MARTIN SK; BLUTE ML; ZINCKE H
      SALVAGE PROSTATECTOMY FOR RADIATION REFRACTORY PROSTATE-CANCER

      The Journal of urology
    70. LOPEZBELTRAN A; PACELLI A; ROTHENBERG HJ; WOLLAN PC; ZINCKE H; BLUTE ML; BOSTWICK DG
      CARCINOSARCOMA AND SARCOMATOID CARCINOMA OF THE BLADDER - CLINICOPATHOLOGICAL STUDY OF 41 CASES

      The Journal of urology
    71. SEAY TM; BLUTE ML; ZINCKE H
      LONG-TERM OUTCOME IN PATIENTS WITH PTXN+ ADENOCARCINOMA OF PROSTATE TREATED WITH RADICAL PROSTATECTOMY AND EARLY ANDROGEN ABLATION

      The Journal of urology
    72. BHUIYAN AKM; RAMAKUMAR S; ROBERTS SG; BLUTE ML; OKANE DJ
      COMPARISON OF SENSITIVITY AND SPECIFICITY BETWEEN SINGLE VOIDED URINEAND CYSTOSCOPICALLY COLLECTED URINE IN THE DETECTION OF BLADDER-CANCER UTILIZING URINARY CYTOLOGY, TELOMERASE, NMP22 AND BTA STAT

      Clinical chemistry
    73. BLUTE ML; BOSTWICK DG; SEAY TM; MARTIN SK; SLEZAK JM; BERGSTRALH EJ; ZINCKE H
      PATHOLOGICAL CLASSIFICATION OF PROSTATE CARCINOMA - THE IMPACT OF MARGIN STATUS

      Cancer
    74. SCHAID DJ; MCDONNELL SK; BLUTE ML; THIBODEAU SN
      EVIDENCE FOR AUTOSOMAL-DOMINANT INHERITANCE OF PROSTATE-CANCER

      American journal of human genetics
    75. CHENG L; NEUMANN RM; BLUTE ML; ZINCKE H; BOSTWICK DG
      LONG-TERM FOLLOW-UP OF UNTREATED STAGE T-1A PROSTATE-CANCER

      Journal of the National Cancer Institute
    76. BLUTE ML; BOSTWICK DG; BERGSTRALH EJ; SLEZAK JM; MARTIN SK; AMLING CL; ZINCKE H
      ANATOMIC SITE-SPECIFIC POSITIVE MARGINS IN ORGAN-CONFINED PROSTATE-CANCER AND ITS IMPACT ON OUTCOME AFTER RADICAL PROSTATECTOMY

      Urology
    77. BLUTE ML
      TRANSURETHRAL MICROWAVE THERMOTHERAPY - MINIMALLY INVASIVE THERAPY FOR BENIGN PROSTATIC HYPERPLASIA

      Urology
    78. VANDERKOOY MJ; PISANSKY TM; CHA SS; BLUTE ML
      IRRADIATION FOR LOCALLY RECURRENT CARCINOMA OF THE PROSTATE FOLLOWINGRADICAL PROSTATECTOMY

      Urology
    79. BLUTE ML
      A NOVEL TRANSURETHRAL MICROWAVE THERMAL ABLATION SYSTEM TO TREAT BENIGN PROSTATIC HYPERPLASIA - RESULTS OF A PROSPECTIVE MULTICENTER CLINICAL - COMMENT

      The Journal of urology
    80. HARMON WJ; SERSHON PD; BLUTE ML; PATTERSON DE; SEGURA JW
      URETEROSCOPY - CURRENT PRACTICE AND LONG-TERM COMPLICATIONS

      The Journal of urology
    81. LERNER SE; BLUTE ML; BERGSTRALH EJ; BOSTWICK DG; EICKHOLT JT; ZINCKE H
      ANALYSIS OF RISK-FACTORS FOR PROGRESSION IN PATIENTS WITH PATHOLOGICALLY CONFINED PROSTATE CANCERS AFTER RADICAL RETROPUBIC PROSTATECTOMY -REPLY

      The Journal of urology
    82. STORKEL S; EBLE JN; ADLAKHA K; AMIN M; BLUTE ML; BOSTWICK DG; DARSON M; DELAHUNT B; ICZKOWSKI K
      CLASSIFICATION OF RENAL-CELL CARCINOMA - WORKGROUP NO 1

      Cancer
    83. HANASH KA; AQUILINA JW; BARRETT DM; BLUTE ML; COCKETT ATK; CORICA FA; HILLMAN GG; ZBAR B; ZHUANG ZP
      CLINICAL RESEARCH PRIORITIES IN RENAL-CELL CARCINOMA - RENAL-CELL CARCINOMA CHEMOPREVENTION STRATEGIES INCLUDING TARGET POPULATIONS, PROPOSED AGENTS, AND CLINICAL-TRIAL DESIGNS - WORKGROUP NO 6

      Cancer
    84. BLUTE ML
      HOW COMMON ARE RENAL ANGIOMYOLIPOMAS IN PATIENTS WITH PULMONARY LYMPHANGIOMYOMATOSIS

      American journal of respiratory and critical care medicine
    85. BLUTE ML; PATTERSON DE; SEGURA JW; TOMERA KM; HELLERSTEIN DK
      TRANSURETHRAL MICROWAVE THERMOTHERAPY V SHAM TREATMENT - DOUBLE-BLINDRANDOMIZED STUDY

      Journal of endourology
    86. PISANSKY TM; BLUTE ML; SUMAN VJ; BOSTWICK DG; EARLE JD; ZINCKE H
      CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH SEMINAL-VESICLE INVASION IN RADICAL PROSTATECTOMY SPECIMENS

      International journal of radiation oncology, biology, physics
    87. LERNER SE; JACOBSEN SJ; LILJA H; BERGSTRALH EJ; RANSOM J; KLEE GG; PIIRONEN T; BLUTE ML; LIEBER MM; ZINCKE H; PETTERSSON K; PETERSON D; OESTERLING JE
      FREE, COMPLEXED, AND TOTAL SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATIONS AND THEIR PROPORTIONS IN PREDICTING STAGE, GRADE, AND DEOXYRIBONUCLEIC-ACID PLOIDY IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE

      Urology
    88. ELLIOTT DS; BLUTE ML; PATTERSON DE; BERGSTRALH EJ; SEGURA JW
      LONG-TERM FOLLOW-UP OF ENDOSCOPICALLY TREATED UPPER URINARY-TRACT TRANSITIONAL-CELL CARCINOMA

      Urology
    89. LERNER SE; BLUTE ML; RICHARDSON RL; ZINCKE H
      PLATINUM-BASED CHEMOTHERAPY FOR ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UPPER URINARY-TRACT

      Mayo Clinic proceedings
    90. BLUTE ML
      HIGH-ENERGY THERMOTHERAPY IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - RESULTS OF EUROPEAN BENIGN PROSTATIC HYPERPLASIA STUDY-GROUP - EDITORIAL COMMENT

      The Journal of urology
    91. LERNER SE; BLUTE ML; BERGSTRALH EJ; BOSTWICK DG; EICKHOLT JT; ZINCKE H
      ANALYSIS OF RISK-FACTORS FOR PROGRESSION IN PATIENTS WITH PATHOLOGICALLY CONFINED PROSTATE CANCERS AFTER RADICAL RETROPUBIC PROSTATECTOMY

      The Journal of urology
    92. KLETSCHER BA; QIAN JQ; BOSTWICK DG; BLUTE ML; ZINCKE H
      PROSPECTIVE ANALYSIS OF THE INCIDENCE OF IPSILATERAL ADRENAL METASTASIS IN LOCALIZED RENAL-CELL CARCINOMA

      The Journal of urology
    93. LERNER SE; HAWKINS CA; BLUTE ML; GRABNER A; WOLLAN PC; EICKHOLT JT; ZINCKE H
      DISEASE OUTCOME IN PATIENTS WITH LOW STAGE RENAL-CELL CARCINOMA TREATED WITH NEPHRON SPARING OR RADICAL SURGERY

      The Journal of urology
    94. LERNER SE; HAWKINS CA; BLUTE ML; GRABNER A; WOLLAN PC; EICKHOLT JT; ZINCKE H
      DISEASE OUTCOME IN PATIENTS WITH LOW STAGE RENAL-CELL CARCINOMA TREATED WITH NEPHRON SPARING OR RADICAL SURGERY - REPLY

      The Journal of urology
    95. BLUTE ML
      PROGNOSTIC-SIGNIFICANCE OF KI-67 LABELING INDEX IN UROTHELIAL TUMORS OF THE RENAL PELVIS AND URETER - COMMENT

      The Journal of urology
    96. LERNER SE; SEAY TM; BLUTE ML; BERGSTRALH EJ; BARRETT D; ZINCKE H
      PROSTATE-SPECIFIC ANTIGEN DETECTED PROSTATE-CANCER (CLINICAL STAGE T1C) - AN INTERIM ANALYSIS

      The Journal of urology
    97. LERNER SE; MANN BS; BLUTE ML; RICHARDSON RL; ZINCKE H
      PRIMARY CHEMOTHERAPY FOR CLINICAL STAGE-II NONSEMINOMATOUS GERM-CELL TESTICULAR-TUMORS - SELECTION CRITERIA AND LONG-TERM RESULTS

      Mayo Clinic proceedings
    98. BLUTE ML
      REFINING THE EARLY DETECTION AND STAGING OF PROSTATE-CANCER

      The Journal of urology
    99. LERNER SE; BLUTE ML; ZINCKE H
      EXTENDED EXPERIENCE WITH RADICAL PROSTATECTOMY FOR CLINICAL STAGE T3 PROSTATE-CANCER - OUTCOME AND CONTEMPORARY MORBIDITY

      The Journal of urology
    100. LERNER SE; BLUTE ML; ZINCKE H
      CRITICAL-EVALUATION OF SALVAGE SURGERY FOR RADIO-RECURRENT RESISTANT PROSTATE-CANCER

      The Journal of urology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/01/21 alle ore 08:55:27